The acetylcholine receptor in normal and pathologic states: Immunoperoxidase visualization of alpha-bungarotoxin binding at a light and electron-microscopic level

Adam N. Bender, Steven P. Ringel, W. King Engel

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Acetylcholine receptor now can be visualized in the muscle sarcolemmal membrane with the use of an immunoperoxidase staining of alpha-bungarotoxin (aBT), a substance that binds specifically to the acetylcholine receptor. This technique has allowed new observations in various neuromuscular diseases in which the acetylcholine receptor is affected. In normal muscle, the acetylcholine receptor is confined to the neuromuscular junction. In both experimental denervation and human denervating illnesses, the acetylcholine receptor becomes present diffusely along the muscle sarcolemmal membrane in denervated fibers. In myasthenia gravis, a circulating factor that blocks a BT binding to the acetylcholine receptor of either normal neuromuscular junctions or denervated sarcolemmal membranes is present in 68 percent of serums tested.

Original languageEnglish
Pages (from-to)477-483
Number of pages7
JournalNeurology
Volume26
Issue number5
DOIs
StatePublished - May 1976

Fingerprint

Dive into the research topics of 'The acetylcholine receptor in normal and pathologic states: Immunoperoxidase visualization of alpha-bungarotoxin binding at a light and electron-microscopic level'. Together they form a unique fingerprint.

Cite this